Biocompatibility and resorption of a brushite calcium phosphate cement. 2005

Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
Musculoskeletal Research Unit (MSRU), Equine Clinic, University of Zurich, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland.

A hydraulic calcium phosphate cement with beta-tricalcium phosphate (TCP) granules embedded in a matrix of dicalcium phosphate dihydrate (DCPD) was implanted in experimentally created defects in sheep. One type of defect consisted of a drill hole in the medial femoral condyle. The other, partial metaphyseal defect was located in the proximal aspect of the tibia plateau and was stabilized using a 3.5 mm T-plate. The bone samples of 2 animals each per group were harvested after 2, 4, 6 and 8 weeks. Samples were evaluated for cement resorption and signs of immediate reaction, such as inflammation, caused by the cement setting in situ. Differences regarding these aspects were assessed for both types of defects using macroscopical, radiological, histological and histomorphometrical evaluations. In both defects the brushite matrix was resorbed faster than the beta-TCP granules. The resorption front was followed directly by a front of new bone formation, in which residual beta-TCP granules were embedded. Cement resorption occurred through (i) extracellular liquid dissolution with cement disintegration and particle formation, and (ii) phagocytosis of the cement particles through macrophages. Signs of inflammation or immunologic response leading to delayed new bone formation were not noticed at any time. Cement degradation and new bone formation occurred slightly faster in the femur defects.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D001843 Bone Cements Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste. Bone Cement,Bone Glues,Bone Pastes,Bone Glue,Bone Paste,Cement, Bone,Cements, Bone,Glue, Bone,Glues, Bone,Paste, Bone,Pastes, Bone
D002130 Calcium Phosphates Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements. Phosphates, Calcium
D005260 Female Females
D005264 Femoral Fractures Fractures of the femur. Femoral Fracture,Fracture, Femoral,Fractures, Femoral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli
D013978 Tibial Fractures Fractures of the TIBIA. Segond Fracture,Tillaux Fracture,Toddler's Fracture,Fracture, Segond,Fracture, Tibial,Fracture, Tillaux,Fracture, Toddler's,Fractures, Tibial,Tibial Fracture,Toddler Fracture,Toddlers Fracture
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017102 Fracture Healing The physiological restoration of bone tissue and function after a fracture. It includes BONY CALLUS formation and normal replacement of bone tissue. Fracture Healings,Healing, Fracture,Healings, Fracture

Related Publications

Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
October 2003, Biomaterials,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
November 2018, Acta biomaterialia,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
April 2006, Biomaterials,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
April 2017, Clinical spine surgery,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
May 2004, Biomaterials,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
February 2016, Journal of biomedical materials research. Part B, Applied biomaterials,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
March 2008, Journal of biomedical materials research. Part A,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
December 2008, Journal of biomedical materials research. Part A,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
December 2012, Materials science & engineering. C, Materials for biological applications,
Felix Theiss, and Detlef Apelt, and Bastian Brand, and Annette Kutter, and Katalin Zlinszky, and Marc Bohner, and Sandro Matter, and Christian Frei, and Joerg A Auer, and Brigitte von Rechenberg
January 2016, Journal of biomaterials applications,
Copied contents to your clipboard!